ClinicalTrials.Veeva

Menu

Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Acute Leukemia

Study type

Observational

Funder types

Other

Identifiers

NCT02344966
4-2010-0732

Details and patient eligibility

About

The objective of this study is to evaluate the prognostic factors of acute leukemia patients and to invent the molecular genetic test for sensitive detection of minimal residual disease, and thereby this study would contribute to plan the risk adapted treatment. Patients will have samples of blood and/or bone marrow collected during diagnosis process, treatment and/or thereafter

Enrollment

1,100 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with acute leukemia in Severance Hospital.
  • Both genders of 16 Years and older
  • sign a written informed consent document

Exclusion criteria

  • No comprehension or willingness to sign a written informed consent document.

Trial contacts and locations

1

Loading...

Central trial contact

JUNE-WON CHEONG, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems